Advanced search×

Olmesartan, microalbuminuria, and type 2 diabetes.

Dimitrios Farmakis and Athanasios Aessopos

N Engl J Med 364(23):2261-2; author reply 2262-3 (2011) PMID 21651398

DOI: 10.1056/NEJMc1104826#SA4
Version: za2963e q8za0 q8zb8 q8zc5 q8zd7 q8ze0 q8zf6 q8zg4
View PDF

Similar articles you may find interesting…

  1. Determinants of lifestyle behavior in type 2 diabetes: results of the 2011 cross-sectional survey on living with chronic diseases in Canada.
    Calypse B Agborsangaya, Marianne E Gee, and Jeffrey A Johnson

    BMC Public Health 13(1):451 (2013) PMID 23647616

    The prevalence of reported dietary change, weight control/loss, increased exercise and smoking cessation (among those who smoked since being diagnosed) were 89.7%, 72.1%, 69.5%, and 30.6%, respectively. Those who reported not receiving health professional advice in the previous 12 months were more l...
    PDF not found
  2. Veterans With Diabetes Receive Arthroplasty More Frequently and at a Younger Age.
    Karen B King, Thomas W Findley, and Allan L Bucknell

    Clin Orthop Relat Res (2013) PMID 23649224

    If these findings hold true for the population as a whole, they imply that clinicians in the United States may see a sharp increase in younger diabetic candidates for joint arthroplasty. LEVEL OF EVIDENCE: Level III, prognostic study. See Guidelines for Authors for a complete description of levels o...
    Buy PDF
  3. Prolonged environmental exposure of arsenic through drinking water on the risk of hypertension and type 2 diabetes.
    Xin Li, Bing Li, and Guifan Sun

    Environ Sci Pollut Res Int (2013) PMID 23649600

    We found that the blood pressure levels were significantly correlated with cumulative arsenic exposure and that the systolic blood pressure of the subjects with arsenic exposure >50 μg/L was significantly higher than those of the subjects with <10 and 10-50 μg/L exposure. Significant prevalence...
    Buy PDF